Exciting news to report: Pittsburgh is the U.S. site for a clinical trial with a gene-independent, cone sparing therapy for retinitis pigmentosa. SparingVision, a French company developing therapies for ocular […]
SparingVision Clinical Trial
retina
Using Optogenetics to Restore Vision
The Department of Ophthalmology at the University of Pittsburgh School of Medicine was the first in the world to use optogenetics to restore vision. The Eye & Ear Foundation’s August […]